M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 13.84 CNY -4.95% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Maccura Biotechnology Co Ltd?
Write Note

Net Margin
Maccura Biotechnology Co Ltd

11.9%
Current
17%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.9%
=
Net Income
325.3m
/
Revenue
2.7B

Net Margin Across Competitors

Country CN
Market Cap 8.5B CNY
Net Margin
12%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 196.3B USD
Net Margin
14%
Country US
Market Cap 170.3B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 36.7B USD
Net Margin
9%
Country US
Market Cap 26.4B USD
Net Margin
21%
Country US
Market Cap 23B USD
Net Margin
17%
Country US
Market Cap 22.3B USD
Net Margin
-36%
No Stocks Found

Maccura Biotechnology Co Ltd
Glance View

Market Cap
8.5B CNY
Industry
Life Sciences Tools & Services

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Intrinsic Value
13.67 CNY
Overvaluation 1%
Intrinsic Value
Price
M

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.9%
=
Net Income
325.3m
/
Revenue
2.7B
What is the Net Margin of Maccura Biotechnology Co Ltd?

Based on Maccura Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 11.9%.